Skip to content

Effectiveness of Pregnancy Tests as an Assessment Tool to Identify Continuing Pregnancy

Evaluating the Effectiveness of Pregnancy Tests as an Assessment Tool to Identify Continuing Pregnancy After Early Medical Abortion

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01856777
Enrollment
600
Registered
2013-05-17
Start date
2013-06-30
Completion date
2014-02-28
Last updated
2014-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Medical Abortion

Keywords

Medical Abortion, Pregnancy Test, continuing pregnancy

Brief summary

This randomized study will examine the effectiveness of two types of pregnancy tests (a semi-quantitative test and a high sensitivity test) to identify continuing pregnancy at home at various time points after early medical abortion. The first test a semi-quantitative panel test marketed under the brand name dBest (AmeriTek, Seattle WA, USA). This urine-based, one-step kit has been used in two previous studies in Vietnam (12, 13). The second test is a locally available urine dipstick (Quickstick one-step hCG Pregnancy Test, Phamatech, San Diego, CA, USA). 1. The investigators hypothesize that 99% of the SQPT and 35% of the HSPT will correctly identify ongoing pregnancy at day 14. 2. The investigators hypothesize that 99% of the SQPT and 25% of the HSPT will correctly identify ongoing pregnancy at day 7. 3. The investigators hypothesize that 75% of the SQPT and 10% of the HSPT will correctly identify ongoing pregnancy at day 4.

Interventions

DEVICESemi-quantitative panel test
DEVICEHigh sensitivity urine pregnancy test

Sponsors

Gynuity Health Projects
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
Yes

Inclusion criteria

* Gestational age ≤63days from LMP * Eligible for mifepristone- misoprostol medical abortion according to clinic guidelines(national guidelines stipulate that women can receive medical abortion thru 63 days LMP at Hung Vuong (tertiary level) hospital; women with gestations up to 49 days LMP can receive medical abortion at Hocmon (district) hospital) * Willing to follow instructions of the provider regarding use of the pregnancy tests * Able to read and write to use pregnancy test at home * Willing to be randomized to perform one of two types of urine pregnancy tests at three time points at home * Willing to provide an address and/or telephone number for purposes of follow-up * Agrees to return for follow-up visit at clinic to confirm abortion status * Wishes to participate in the study * Able to consent to study participation

Exclusion criteria

* Women not meeting the above inclusion criteria

Design outcomes

Primary

MeasureTime frameDescription
Accuracy of these two types of home pregnancy tests2 weeksAccuracy of these two types of home pregnancy tests to identify continuing pregnancy at four, seven and fourteen days after mifepristone administration.

Secondary

MeasureTime frameDescription
Comparison of the two types of pregnancy tests at identifying continuing pregnancy2 weeks
The use and acceptability of the two tests2 weeksThe use and acceptability of the two tests for women as a diagnostic tool to assess pregnancy status at home following early medical abortion
Correlation between the pregnancy test results determined by the woman at home and the abortion outcome determined by provider2 weeks

Countries

Vietnam

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026